Providing Pharmacogenomics to Senior Living with Frank Howard, CEO of GeneIQ

Frank G Howard, CEO of GeneIQ, comes from a place of experience when it comes to dealing with various struggles in life, whether that be personally, with family health, or bringing purpose in his daily work. This need for purpose is what's driven him to head up GeneIQ, where they take genetics into account to guide treatment decisions and improve patient wellness. What's more, they've found that 75% of senior living residents who were tested have multiple recommendations for medication changes based on their genetics.

He describes residents who are undergoing medication trial and error crying in a hallway, transforming their struggles into joy when appropriate medication is applied. But something like this needs to be a larger part of a system that keeps a community running. He also explains what goes into the backend of something like this, from how they integrate with existing resident tracking systems, to ensuring protection of personal health information.

Listen to this episode and learn more at geneiqlab.com